Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics cash
Cash and short-term investments held at the end of each period.
Whitehawk Therapeutics's cash was $190.00M at Jun 30, 2026. For fiscal 2025 it was $145.70M, up 208.7% from the year before. Over ten years it grew 39.7% a year on average. The highest annual figure on record is $172.60M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $145.70M | +208.7% |
| FY2024 | Dec 31, 2024 | $47.20M | -56.6% |
| FY2023 | Dec 31, 2023 | $108.80M | -37.0% |
| FY2022 | Dec 31, 2022 | $172.60M | +15.8% |
| FY2021 | Dec 31, 2021 | $148.99M | +3244.3% |
| FY2020 | Dec 31, 2020 | $4.46M | -88.4% |
| FY2019 | Dec 31, 2019 | $38.52M | -38.5% |
| FY2018 | Dec 31, 2018 | $62.61M | +209.0% |
| FY2017 | Dec 31, 2017 | $20.26M | +1121.0% |
| FY2016 | Dec 31, 2016 | $1.66M | -67.7% |
| FY2015 | Dec 31, 2015 | $5.14M | +97642.9% |
| FY2014 | Dec 31, 2014 | $5.26K | -16.2% |
| FY2013 | Dec 31, 2013 | $6.28K | +36.4% |
| FY2012 | Dec 31, 2012 | $4.61K | +11.7% |
| FY2011 | Dec 31, 2011 | $4.13K | -84.7% |
| FY2010 | Dec 31, 2010 | $26.90K | +141.4% |
| FY2009 | Dec 31, 2009 | $11.14K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $190.00M | +7.2% |
| Q1 FY2026 | Mar 31, 2026 | $123.00M | -46.8% |
| Q4 FY2025 | Dec 31, 2025 | $145.70M | +208.7% |
| Q3 FY2025 | Sep 30, 2025 | $162.60M | +159.7% |
| Q2 FY2025 | Jun 30, 2025 | $177.20M | +125.4% |
| Q1 FY2025 | Mar 31, 2025 | $231.10M | +161.7% |
| Q4 FY2024 | Dec 31, 2024 | $47.20M | -56.6% |
| Q3 FY2024 | Sep 30, 2024 | $62.60M | -47.5% |
| Q2 FY2024 | Jun 30, 2024 | $78.60M | -41.7% |
| Q1 FY2024 | Mar 31, 2024 | $88.30M | -41.6% |
| Q4 FY2023 | Dec 31, 2023 | $108.80M | -37.0% |
| Q3 FY2023 | Sep 30, 2023 | $119.30M | -34.8% |
| Q2 FY2023 | Jun 30, 2023 | $134.90M | +13.6% |
| Q1 FY2023 | Mar 31, 2023 | $151.20M | +16.4% |
| Q4 FY2022 | Dec 31, 2022 | $172.60M | +15.8% |
| Q3 FY2022 | Sep 30, 2022 | $183.00M | +13.4% |
| Q2 FY2022 | Jun 30, 2022 | $118.74M | +222.5% |
| Q1 FY2022 | Mar 31, 2022 | $129.85M | +232.9% |
| Q4 FY2021 | Dec 31, 2021 | $148.99M | +3244.3% |
| Q3 FY2021 | Sep 30, 2021 | $161.38M | +241.3% |
| Q2 FY2021 | Jun 30, 2021 | $36.82M | -17.9% |
| Q1 FY2021 | Mar 31, 2021 | $39.01M | +12.8% |
| Q4 FY2020 | Dec 31, 2020 | $4.46M | -88.4% |
| Q3 FY2020 | Sep 30, 2020 | $47.28M | +9.0% |
| Q2 FY2020 | Jun 30, 2020 | $44.86M | -6.8% |
| Q1 FY2020 | Mar 31, 2020 | $34.58M | -35.3% |
| Q4 FY2019 | Dec 31, 2019 | $38.52M | -38.5% |
| Q3 FY2019 | Sep 30, 2019 | $43.39M | -36.9% |
| Q2 FY2019 | Jun 30, 2019 | $48.16M | -30.0% |
| Q1 FY2019 | Mar 31, 2019 | $53.42M | +288.1% |
| Q4 FY2018 | Dec 31, 2018 | $62.61M | +209.0% |
| Q3 FY2018 | Sep 30, 2018 | $68.81M | +176.6% |
| Q2 FY2018 | Jun 30, 2018 | $68.78M | +138.0% |
| Q1 FY2018 | Mar 31, 2018 | $13.76M | -60.9% |
| Q4 FY2017 | Dec 31, 2017 | $20.26M | +1121.0% |
| Q3 FY2017 | Sep 30, 2017 | $24.88M | +1801.5% |
| Q2 FY2017 | Jun 30, 2017 | $28.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $35.19M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.66M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.31M | – |
See a number that looks wrong?